© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Movement Disorders
The NeurologyLive movement disorders clinical focus page is a source for all the latest news regarding the clinical care of patients with Parkinson disease, essential tremor, Huntington disease, dystonia, ataxia, and more. This page features podcasts, videos, and news about FDA actions, study and clinical trial findings, clinical guideline updates, and interviews with experts in the clinical care of movement disorders.
Genetic Testing Cost for Huntington Disease Nonstandard Across Centers of Excellence
September 20, 2021
Article
A study from the International Parkinson and Movement Disorder Society Virtual Congress suggest that despite protocol adherence, average costs are moderately high and vary significantly.
Improving Care in Dystonia via Medical Cannabis: Saar Anis, MD
September 20, 2021
Video
The neurologist and movement disorders specialist at Sheba Tel-HaShomer Medical Center in Israel discussed future use of medical cannabis and concerns for psychiatric adverse effects.
Efficacy of Medical Cannabis for the Treatment of Dystonia: Saar Anis, MD
September 20, 2021
Video
The neurologist and movement disorders specialist at Sheba Tel-HaShomer Medical Center in Israel outlined the small, retrospective study, shedding light on its findings.
This Week on NeurologyLive — September 20, 2021
September 20, 2021
Article
Here's what is coming soon to NeurologyLive.
Noncontact Boxing Exercise Assessed for Parkinson Disease Benefit
September 19, 2021
Article
The FIGHT-PD study is expected to complete and read out interim results before the end of 2021. It aims to assess the exercise program’s safety, tolerability, and efficacy in Parkinson disease.
State of Care for Patients With Parkinson Disease: William Ondo, MD
September 19, 2021
Video
The professor of neurology at Weill Cornell Medical School commented on the available treatments for Parkinson disease, as well as ongoing therapeutic development.
Omaveloxolone Continues to Demonstrate Positive Effect on Friedrich Ataxia
September 19, 2021
Article
Patients previously randomized to omaveloxolone in the core study period continued to show no worsening on modified Friedrich Ataxia Rating Scale relative to their original baseline after nearly 2.5 years of treatment.
Home Health DBS Management Proves Feasible for Parkinson Disease
September 18, 2021
Article
Patients who underwent deep brain stimulation procedures that were managed postoperatively in the home reported significantly fewer clinic visits with similar MDS-UPDRS scores to standard of care.
Medical Cannabis Improves Related Pain, Symptoms of Dystonia
September 18, 2021
Article
Investigators noted the psychiatric adverse effects of treatment with medical cannabis, requiring patient monitoring after initiation.
Prasinezumab Shows Potential Effect of Delaying Motor Progression in Parkinson Disease
September 18, 2021
Article
Despite not meeting the primary end point, those in the early-start group showed reduced change from baseline in MDS-UPDRS-III scores compared with the delayed-start group at both weeks 52 and 104.